Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

AGEN News and Commentary

Caps

How do you think AGEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

198 Outperform
84 Underperform
 

All-Star Players

23 Outperform
25 Underperform
 

Wall Street

6 Outperform
0 Underperform
 

Top AGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.73)
Submitted April 03, 2013

I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to… More

Ernbo6 (48.29)
Submitted May 15, 2007

Antigenics Inc. is a biotechnology company developing technologies and products to treat cancers, infectious diseases and autoimmune disorders, primarily based on immunological approaches. Its advanced product candidate is Oncophage (vitespen,… More

AGEN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about AGEN.

Recs

0
Member Avatar TMFang4apples (47.14) Submitted: 8/11/2017 2:20:27 PM : Outperform Start Price: $3.53 AGEN Score: -71.80

While it's understandable for Bristol-Myers to take a beating after AstraZeneca's PD-1 CTLA-4 combo failed, Agenus is a much smaller company. Any success with its clinical stage candidates, including inhibitors of other checkpoints licensed to Incyte, will lead to market thumping gains from this level.

Recs

0
Member Avatar rocknrook (55.91) Submitted: 6/27/2017 7:53:50 AM : Outperform Start Price: $4.01 AGEN Score: -77.89

Assuming effective test results. I like that there is significant interest from big players in partnering.

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/2/2017 3:52:31 PM : Outperform Start Price: $4.16 AGEN Score: -81.55

Tries to harness immunity to fight disease. In other words: another hopeful biotech. Or maybe it's just me who's hopeful.

Leaderboard

Find the members with the highest scoring picks in AGEN.

Score Leader

epc53

epc53 (27.79) Score: +299.20

The Score Leader is the player with the highest score across all their picks in AGEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
svande8952 25.81 6/16/2009 Underperform 5Y $12.24 -87.01% +211.47% +298.48 1 Comment
1or5stars 99.79 6/8/2009 Underperform 3W $13.68 -88.38% +207.60% +295.98 0 Comment
TWreckz 99.33 6/5/2009 Underperform 5Y $15.90 -90.00% +202.21% +292.21 0 Comment
rcbaldwinjr 70.70 8/5/2009 Underperform 3W $13.85 -88.52% +187.80% +276.32 0 Comment
rhinomaj 92.72 8/4/2009 Underperform 3M $14.34 -88.91% +185.99% +274.90 0 Comment
epc53 27.79 8/7/2009 Underperform 5Y $13.26 -88.01% +184.37% +272.38 0 Comment
BadCopNoDonuts < 20 7/28/2010 Underperform 5Y $5.64 -71.81% +156.63% +228.44 0 Comment
JackOffBadApples 89.58 9/12/2008 Underperform 3W $10.02 -84.13% +137.11% +221.24 0 Comment
DayTr8der88 < 20 9/22/2008 Underperform NS $9.90 -83.94% +135.25% +219.19 0 Comment
chop3399 < 20 3/13/2008 Underperform 5Y $13.44 -88.17% +129.72% +217.89 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.44 1/9/2015 Outperform 3W $5.29 -69.94% +39.87% -109.81 0 Comment
TrackWMBlair 81.26 1/5/2012 Outperform NS $2.12 -25.00% +123.33% -148.33 0 Comment
trackglobalhunte < 20 12/1/2011 Outperform NS $2.44 -34.84% +128.82% -163.65 0 Comment
trackmlvcapital < 20 9/13/2011 Outperform NS $3.42 -53.51% +144.07% -197.58 0 Comment
TrackDawsonJames < 20 6/1/2011 Outperform NS $5.58 -71.51% +112.39% -183.89 0 Comment
TrackRodmanRen < 20 5/9/2011 Outperform NS $5.75 -72.36% +111.72% -184.09 0 Comment

Featured Broker Partners


Advertisement